Thromboprophylaxis in atrial fibrillation: why, how, when and how can we do better?

Int J Clin Pract. 2006 Mar;60(3):252-5. doi: 10.1111/j.1368-5031.2006.0884b.x.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anticoagulants / therapeutic use*
  • Aspirin / therapeutic use
  • Atrial Fibrillation / complications*
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Thromboembolism / prevention & control*
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Warfarin
  • Aspirin